146
Participants
Start Date
January 31, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Abraxane (nab-paclitaxel)
Gemcitabine
Cambridge University Hospitals NHS Foundation Trust, Cambridge
Peterborough City Hospital, Peterborough
Ysbyty Gwynedd, Bangor
Queen Elizabeth Hospital, Birmingham
Bristol Haematology & Oncology Centre, Bristol
Velindre Cancer Centre, Cardiff
Edinburgh Cancer Research Centre, Edinburgh
The Beatson Oncology Centre, Glasgow
The Royal Surrey County Hospital, Guildford
St James' Institute of Oncology, Leeds
Clatterbridge Cancer Centre, Liverpool
Hammersmith Hospital, London
The Royal Free Hospital, London
University College London Hospital, London
The Christie Hospital, Manchester
Churchill Hospital, Oxford
Weston Park Hospital, Sheffield
Royal Cornwall Hospital, Truro
Belfast City Hospital, Belfast
Colchester Hospital, Colchester
University Hospitals Coventry & Warwickshire, Coventry
Leicester Royal Infirmary, Leicester
Barts Health NHS Trust, London
Collaborators (1)
Celgene
INDUSTRY
CCTU- Cancer Theme
OTHER